Tennesseans’ opportunities to access clinical trial drugs are more limited than other parts of the country. But, a year-old initiative out of a local university is getting the state’s residents enrolled in early drug and medical device access.
“This network meets a huge need for University of Tennessee Health Science Center (UTHSC) clinical research,” said Steve Goodman, president and CEO of the Clinical Trials Network of Tennessee (CTN2) and a vice chancellor for research at UTHSC, in a release. “CTN2 takes patient care to the next level by opening up access to novel therapies and medical devices.”